$STX

Romano Gianluca sold $744K of STX

Romano Gianluca (EVP & CFO) sold 880 shares of Seagate Technology Holdings plc (STX) at an average of $845.12 ($835.77–$850.04, $0.74M total) across 8 trades on 2026-08-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Romano Gianluca
Published Aug 11, 2026, 8:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
high confidence
Mentioned
$STX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The disclosed event is an open-market sale of 880 shares at a weighted average price of $845.12, totaling $743,705.61, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the CFO’s 10b5-1 selling as a small sentiment datapoint, but there is no new fundamental catalyst in the text.

03

What to watch

The article does not state whether the sale was part of a broader planned schedule, nor does it include any concurrent buy activity or new guidance.

Relevance 4/10Novelty 3/10Timing: Filed 2026-08-11, describing sales executed 2026-08-07.

Background

The article is a SEC Form 4 insider transaction for Seagate Technology Holdings plc, reported by its EVP and CFO.

Company-level read

Ticker impact

$STXNeutralHigh confidence
Context

Seagate CFO Romano Gianluca sold $743,705 of STX shares via an open-market sale under a pre-arranged 10b5-1 plan on 2026-08-07.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and typically fades unless paired with other negative news.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and the article provides no new company fundamentals beyond the sale details.

Market effects

Minimal, as this is company-specific insider selling with no sector-wide signal provided.

None indicated.

None indicated.

Counterpoint

Insider sales can be tax- or diversification-driven and may not reflect bearish expectations, especially under a 10b5-1 plan.

Key entities

  • Seagate Technology Holdings plc

    Subject of the Form 4 insider transaction; CFO sold shares under a 10b5-1 plan.

  • Romano Gianluca

    EVP and CFO who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.